BIT Capital GmbH boosted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 5,711.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,473,853 shares of the company's stock after acquiring an additional 4,396,872 shares during the period. Oscar Health comprises approximately 4.8% of BIT Capital GmbH's portfolio, making the stock its 8th largest position. BIT Capital GmbH owned approximately 1.81% of Oscar Health worth $60,129,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in OSCR. Arizona State Retirement System increased its holdings in shares of Oscar Health by 3.1% in the 4th quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after acquiring an additional 1,454 shares during the period. Xponance Inc. boosted its stake in shares of Oscar Health by 12.9% during the fourth quarter. Xponance Inc. now owns 14,394 shares of the company's stock worth $193,000 after buying an additional 1,649 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Oscar Health by 9.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock worth $561,000 after buying an additional 2,236 shares during the last quarter. KBC Group NV increased its position in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after acquiring an additional 2,555 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in Oscar Health by 20.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 17,896 shares of the company's stock valued at $241,000 after acquiring an additional 3,040 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.
Analyst Ratings Changes
Several research analysts have weighed in on OSCR shares. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Jefferies Financial Group started coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.21.
Get Our Latest Analysis on Oscar Health
Oscar Health Price Performance
NYSE:OSCR traded down $0.29 during trading hours on Monday, hitting $13.01. The company's stock had a trading volume of 1,249,948 shares, compared to its average volume of 3,748,448. Oscar Health, Inc. has a 52-week low of $12.43 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The business's 50-day moving average is $14.90 and its two-hundred day moving average is $16.05. The company has a market capitalization of $3.26 billion, a PE ratio of -649.93 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.